Soterix Medical Inc. Announces Phase 3 Clinical Trial for Depression Comparing …

Soterix Medical Inc. announces Phase 3 Clinical Trial for Depression comparing …
However, Soterix Medical also recognizes that tDCS may be applied in conjunction or as an alternative to drug medication. Indeed, many patients suffering from Major Depressive Disorders are insufficiently responsive to medication or suffer side-effects. Read more on PR Newswire (press release)

Deep brain stimulation shows early promise for depression
BARCELONA – Assessment of deep brain stimulation for patients with treatment-resistant depression has inched forward over the past decade with promising results but remains in its early days with a total worldwide experience of roughly 60 patients. Read more on Clinical Psychiatry News Digital Network

depression in men – Being overweight clients who actually at this time be depressed find more noted brain downfall in contrast to those without the presence of clinical depressi…